{Reference Type}: Case Reports
{Title}: Peyronie's disease in a patient after COVID-19 infection: A case report.
{Author}: Rainer Q;Molina M;Ibrahim E;Saltzman R;Masterson T;Ramasamy R;
{Journal}: Andrologia
{Volume}: 53
{Issue}: 11
{Year}: Dec 2021
{Factor}: 2.532
{DOI}: 10.1111/and.14219
{Abstract}: Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by a novel coronavirus (SARS-CoV-2), which demonstrates the ability to invade endothelial cells and cause systemic inflammation. Many possible long-term sequelae of COVID-19 remain unidentified. We describe a case of a man who developed Peyronie's disease after a resolved COVID-19 infection. Erectile dysfunction was confirmed by the International Index of Erectile Function-15(IIEF) and Sexual Health Inventory for Men(SHIM) scores. A diagnosis was Peyronie's disease was confirmed on ultrasound. Furthermore, he was found to have low endothelial progenitor cells colony-forming units and low brachial artery flow-mediated vasodilation, both of that are indicative of endothelial dysfunction. This case suggests Peyronie's disease should be considered as a possible sequela of COVID-19 infection and providers should inquire about a history of COVID-19 infection in patients presenting with Peyronie's disease.